Amidst the ongoing COVID-19 pandemic, concerns have been raised about the safety and composition of certain COVID-19 vaccines. A collaborative study conducted by the University of Guelph, Sy… Read More
BioNTech warns of write-off of up to 900 million euros on COVID vaccine
By Ludwig Burger
BERLIN (Reuters) – Shares in Germany’s BioNTech fell on Monday after it flagged write-dow… Read More
CoronavírusSiga-nosUm recente estudo realizado em Israel estabeleceu uma ligação entre a infecção pelo COVID-19 e um aumento significativo no diagn&o… Read More
Die von Karl Lauterbach enorme Wirksamkeit der Genplörre von BioNTech/Pfizer bei Kindern bezog sich natürlich nicht auf einen Infektionsschutz, wie Lauterbach wahrheitswidrig angab… Read More
German attorney Tobias Ulbrich has accused his country’s health bureau of failing to properly supervise the COVID-19 vaccine, saying the bureau is a promoter of questionable drugs and… Read More
Pfizer’s foggy COVID outlook hits vaccine maker shares By Michael Erman and Manas Mishra (Reuters) -Pfizer on Monday set off a fresh round of concern about the size of the COVID-19 vac… Read More
Compared with viral vectors, non-viral delivery vectors are easier to scale up and have the ability to solve the most critical safety issues. Thanks to the LNP-mRNA vaccine that came to the… Read More
STOCKHOLM (AP) Two scientists won the Nobel Prize in medicine on Monday for discoveries that enabled the creation of mRNA vaccines against COVID-19 that were critical in slowing the pandemi… Read More
Moderna has announced that its combination vaccine, mRNA-1083, targeting both Covid-19 and the flu, will move to a final stage trial in adults aged 50 and above this year after showing posit… Read More